| 000 | 01575 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515072453.0 | ||
| 264 | 0 | _c20080414 | |
| 008 | 200804s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Jian-ming | |
| 245 | 0 | 0 |
_a[Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cJan 2007 |
||
| 300 |
_a66-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aExanthema _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLi, Yue-min | |
| 700 | 1 | _aLiu, Xiao-qing | |
| 700 | 1 | _aZhang, Yang | |
| 700 | 1 | _aHan, Yu | |
| 700 | 1 | _aYang, Wu-wei | |
| 700 | 1 | _aSong, San-tai | |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 29 _gno. 1 _gp. 66-9 |
|
| 999 |
_c17113465 _d17113465 |
||